Cent Eur J Public Health 2018, 26(Supplement):S67-S71 | DOI: 10.21101/cejph.a5442

Seroprevalence of Lyme disease in Eastern Slovakia

Andrea Bušová1, Erik Dorko1, Kvetoslava Rimárová1, Jana Diabelková1, Tímea Rovenská1, Eva Feketeová2, Matúš Bereš3, Róbert Čellár3, Zuzana Baranová4, Tomáš Kampe4, Karim Benhatchi5
1 Department of Public Health and Hygiene, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovak Republic
2 Department of Neurology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice and Louis Pasteur University Hospital, Košice, Slovak Republic
3 Department of Orthopaedics and Traumatology of Locomotory Apparatus, Faculty of Medicine, Pavol Jozef Šafárik University in Košice and Louis Pasteur University Hospital, Košice, Slovak Republic
4 Department of Dermatovenerology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice and Louis Pasteur University Hospital, Košice, Slovak Republic
5 1st Department of Internal Medicine, Faculty of Medicine, Pavol Jozef Šafárik University in Košice and Louis Pasteur University Hospital, Košice, Slovak Republic

Objective: Lyme disease (LD) is chronic, multi-system zoonosis transmitted by ticks, and LD aetiological agents are spirochetes of the Borrelia burgdorferi sensu lato complex. The aim of the cross-sectional study was to analyze the LD incidence on the basis of the presence of specific antibodies in the serum of patients in Eastern Slovakia, and to compare the results of serological ELISA and immunoblot assays.

Methods: Venous blood with questionnaires was obtained by field sampling of respondents from Eastern Slovakia. Overall, we examined 537 human sera by the ELISA and for confirmation we tested all positive IgG antibodies against the Borrelia immunoblot assay.

Results: Our results confirmed the high serum prevalence of anti-Borrelia antibodies (17.9% for IgG), while the immunoblot seropositive test was confirmed in 69.8% of responders from ELISA IgG positive sera. Positive antibodies of the IgM class were found in 7.6% of the population under study. Most commonly found were antibodies against VlsE (80.2%), p41 (66.7%), p18 (56.3%), p100 (41.7%), p58 (31.3%), and p39 (30.2%).

Conclusion: It should be noted that detection of antibodies against B. burgdorferi s.l. is only an indirect evidence of the presence of this bacterium in the development of clinical signs of LD in humans. Laboratory LD tests should be performed in accordance with valid standards, positive and uncertain results must be confirmed by the Western Blot/Immunoblot assay.

Klíčová slova: Lyme disease, diagnosis, seroprevalence

Vloženo: 27. červen 2018; Revidováno: 30. listopad 2018; Přijato: 30. listopad 2018; Zveřejněno: 31. prosinec 2018  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bušová A, Dorko E, Rimárová K, Diabelková J, Rovenská T, Feketeová E, et al.. Seroprevalence of Lyme disease in Eastern Slovakia. Cent Eur J Public Health. 2018;26(Supplement):S67-71. doi: 10.21101/cejph.a5442. PubMed PMID: 30817877.
Stáhnout citaci

Reference

  1. Tomao P, Ciceroni L, D'Ovidio MC, De Rosa M, Vonesch N, Iavicoli S, et al. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy. Eur J Clin Microbiol Infect Dis. 2005;24(7):457-63. Přejít k původnímu zdroji... Přejít na PubMed...
  2. Medlock JM, Hansford KM, Bormane A, Derdakova M, Estrada-Peña A, George J-C, et al. Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe. Parasit Vectors. 2013;6:1. Přejít k původnímu zdroji... Přejít na PubMed...
  3. Jovanovic D, Atanasievska S, Protic-Djokic V, Rakic U, Lukac-Radoncic E, Ristanovic E. Seroprevalence of Borrelia burgdorferi in occupationally exposed persons in the Belgrade area, Serbia. Braz J Microbiol. 2015;46(3):807-14. Přejít k původnímu zdroji... Přejít na PubMed...
  4. Tokarska-Rodak M, Fota-Markowska H, Kozioł-Montewka M, Śmiechowicz F, Modrzewska R. The detection of specific antibodies against B. burgdorferi s. s., B. afzelii, B. garinii, and B. spielmani antigens in patients with Lyme disease in eastern Poland. New Med. 2010;3:84-7.
  5. Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and management of Lyme disease. Am Fam Physician. 2012;85(11):1086-93. Přejít na PubMed...
  6. Dorko E. Lyme borreliosis, characteristics, epidemiology, treatment, prevention, environmental and social aspects of occurrence. In: Rimárová K, Barlašová-Dunajová M, Bušová A, Diabelková J, Dorko E, Hamráková M, et al. Selected health parametres of the Romany Gypsy population in the Slovak Republic. Košice: Equlibria; 2017. p. 230-62. (In Slovak.)
  7. Marques, AR. Laboratory diagnosis of Lyme disease - advances and challenges. Infect Dis Clin North Am. 2015;29(2):295-307. Přejít k původnímu zdroji... Přejít na PubMed...
  8. Borchers AT, Keenb CL, Huntleyc AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015; 57:82-115. Přejít k původnímu zdroji... Přejít na PubMed...
  9. Public Health Authorities of the Slovak Republic. Annual report [Internet]. Bratislava: Public Health Authorities of the Slovak Republic; 2017 [cited 2018 May 27]. Available from: http://www.uvzsr.sk/docs/vs/vyrocna_sprava_SR_2017.pdf/. (In Slovak).
  10. Ogden NH, Arsenault J, Hatchette TF, Mechai S, Lindsay LR. Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada. PLoS One. 2017;12(2):e0171731. Přejít k původnímu zdroji... Přejít na PubMed...
  11. Bil-Lula I, Matuszek P, Pfeiffer T, Woźniak M. Lyme Borreliosis - the Utility of Improved Real-Time PCR Assay in the Detection of Borrelia burgdorferi Infections. Adv Clin Exp Med. 2015;24(4):663-70. Přejít k původnímu zdroji... Přejít na PubMed...
  12. Pańczuk A, Koziol-Montewka M, Tokarska-Rodak M. Exposure to ticks and seroprevalence of Borrelia burgdorferi among a healthy young population living in the area of southern Podlasie, Poland. Ann Agric Environ Med. 2014;21(3):512-17. Přejít k původnímu zdroji... Přejít na PubMed...
  13. Leeflang MM, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, et al. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect Dis. 2016;16:140. Přejít k původnímu zdroji... Přejít na PubMed...
  14. Kaya DA, Parlak HA, Ozturk EC, Behcet M. Seroprevalence of Borrelia burgdorferi infection among forestry workers and farmers in Duzce, north-western Turkey. New Microbiol. 2008;(31):203-9.
  15. Biesiada G, Czepiel J, Salamon D, Garlicki A, Dziubek A, Maziarz B, et al. Analysis of Borrelia burgdorferi genostrains among patients with Lyme disease. Przegl Lek. 2009;66:511-2. (In Polish). Přejít na PubMed...
  16. Wojciechowska-Koszko I, Mączyńska I, Szych Z, Giedrys-Kalemba S. Serodiagnosis of borreliosis: indirect immunofluorescence assay, enzyme-linked immunosorbent assay and immunoblotting. Arch Immunol Ther Exp (Warsz). 2011;59(1):69-77. Přejít k původnímu zdroji... Přejít na PubMed...
  17. Kubiak K, Dzika E, Równiak J, Dziedziech M, Dzisko J. Seroprevalence of Lyme disease and genospecies of Borrelia burgdorferi sensu lato in patients diagnosed with borreliosis in the Province of Warmia-Masuria in north-eastern Poland. Ann Agric Environ Med. 2012;19(2):203-7.
  18. van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993;17(4):708-17. Přejít k původnímu zdroji... Přejít na PubMed...
  19. Sicklinger M, Wienecke R, Neubert U. In vitro susceptibility testing for four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. J Clin Microbiol. 2003;41(4):1791-3. Přejít k původnímu zdroji... Přejít na PubMed...